{"id":42308,"date":"2014-04-02T00:00:00","date_gmt":"2014-04-01T22:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/caixa-capital-risc-lanza-nuevo-fondo-en-el-sector-de-la-biotecnologico\/"},"modified":"2025-03-12T11:24:45","modified_gmt":"2025-03-12T10:24:45","slug":"caixa-capital-risc-lanza-nuevo-fondo-en-el-sector-de-la-biotecnologico","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/caixa-capital-risc-lanza-nuevo-fondo-en-el-sector-de-la-biotecnologico\/","title":{"rendered":"Caixa Capital Risc launches a new fund in the Biotech sector"},"content":{"rendered":"<address><span style=\"color: #000000;\"><a href=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/descarga-1.jpg\"><img decoding=\"async\" class=\"alignleft wp-image-4267\" title=\"private equity\" src=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/descarga-1.jpg\" alt=\"private equity\" width=\"154\" height=\"57\" \/><\/a><\/span><span style=\"color: #000000;\"><a href=\"https:\/\/www.criteriacaixa.com\/cartera-de-inversiones\/cartera-industrial-y-de-servicios\/negocio-de-venture-capital\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">Caixa Capital Risc<\/span><\/a>the \"la Caixa\" group's venture capital manager for innovative companies in the early stages, which had 4 investment vehicles specialising in Biotechnology, Industry and ICT, has launched a new Biotechnology fund together with the CDTI.<!--more--><\/span><\/address>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #3366ff;\"><strong>Experience in the biotechnology sector<\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\">La Caixa already had,\u00a0<span style=\"text-decoration: underline;\"><span style=\"color: #000000; text-decoration: underline;\">Caixa Capital BioMed<\/span><\/span>The company, a <strong>private equity<\/strong> with a total committed capital of \u20ac23 million to invest in medical technology, new therapies, diagnostics and services. Since its creation in 2011, the vehicle <strong>has invested<\/strong> 14m in 13 companies, which have raised more than <strong>private investment<\/strong> national and international support for their business projects.<\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>Transactions carried out<\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\">Among the companies that have received funding are\u00a0<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.stat-diagnostica.com\/\" data-cke-saved-href=\"http:\/\/www.stat-diagnostica.com\/\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">STAT-DIAGNOSTICA<\/span><\/a><\/span>\u00a0which designs, develops, manufactures and markets a system that integrates molecular diagnostic and immunoassay tests in a device and cartridges. Together with Caixa Capital BioMed also participated in the series B round, which raised \u20ac17M.\u00a0\u00a0<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.kls-partners.com\/\" data-cke-saved-href=\"http:\/\/www.kls-partners.com\/\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">Kurma Life Sciences Partners<\/span><\/a><\/span>,\u00a0<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.ysioscapital.com\/\" data-cke-saved-href=\"http:\/\/www.ysioscapital.com\/\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">\u00a0Ysios Capital,<\/span><\/a><\/span>\u00a0<span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.axispart.com\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">Axis<\/span><\/a><\/span>,\u00a0\u00a0<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.idinvest.com\/\" data-cke-saved-href=\"http:\/\/www.idinvest.com\/\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">Idinvest<\/span><\/a><\/span>,<span style=\"text-decoration: underline;\"><span class=\"removed_link\" title=\"http:\/\/www.boehringer-ingelheim-venture.com\/\"><span style=\"color: #000000; text-decoration: underline;\">\u00a0Boehringer Ingelheim Venture Fund.<\/span><\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\">Another recent operation, carried out in February 2014, involves\u00a0<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.genmedica.com\/\" data-cke-saved-href=\"http:\/\/www.genmedica.com\/\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">Genmedica Therapeutics.\u00a0<\/span><\/a><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\">The Catalan biopharmaceutical company Genmedica Therapeutics has completed a<strong> financing round<\/strong> 1M to finance the development of a drug for the treatment of type 2 diabetes. The capital increase was mainly covered by the company's own shareholders, including Caixa Capital Risc.<\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>Caixa Invests Biomed<\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\">The new fund, Caixa Innvierte BioMed II, which has the support of the\u00a0<span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.cdti.es\/\" data-cke-saved-href=\"https:\/\/www.cdti.es\/\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">CDTI<\/span><\/a><\/span>\u00a0and will have an investment volume of \u20ac35M will enable Caixa Capital BioMed to complete its investment period and focus on the value creation of its investee companies.<\/span><\/p>\n<p><span style=\"color: #000000;\">\"The creation of the <strong>new fund<\/strong> shows us the interest that Caixa Capital Risc , which sees an opportunity in the Biotechnology sector, and according to the latest report of the Spanish Association of Biocompanies (<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.asebio.com\/es\/index.cfm\" data-cke-saved-href=\"http:\/\/www.asebio.com\/es\/index.cfm\" data-cke-saved- target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">ASEBIO<\/span><\/a><\/span>), Spain ranks ninth in the world and fifth at European level in scientific production, a sector that in 2013 accounted for 7.15% of Spain's GDP. In 2011, there were 3,025 companies related to biotechnology activities in the country. There is a strong culture of spin-off in the sector, with between 10 and 12 new companies being created every year from public institutions,\" says Diego Gutierrez, the group's expert in alternative finance.\u00a0<span style=\"text-decoration: underline;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/\" data-cke-saved-href=\"https:\/\/techma.bakertilly.es\/\" data-cke-saved-><span style=\"color: #000000; text-decoration: underline;\">Abra Invest.<\/span><\/a><\/span><\/span><\/p>\n<p><strong><span style=\"color: #3366ff;\">Other posts that may interest you<\/span><\/strong><\/p>\n<p><span style=\"text-decoration: underline;\"><span style=\"color: #000000;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/ultimas-inversiones-en-diagnostico-de-enfermedades\/\"><span style=\"color: #000000; text-decoration: underline;\">Latest investments in \"disease diagnostics<\/span><\/a><\/span><\/span><\/p>\n<p><a href=\"https:\/\/techma.bakertilly.es\/en\/desde-el-2007-el-private-equity-americano-ha-invertido-2400mm-en-el-sector-del-healthcare\/\"><span style=\"text-decoration: underline;\">\u00a0Since 2007, US private equity has invested 2400MM$ in the healthcare sector.<\/span><\/a><\/p>\n<p><a href=\"https:\/\/techma.bakertilly.es\/en\/healthcare-nota-el-impacto-de-la-crisis\/\"><span style=\"text-decoration: underline;\"><span style=\"color: #000000; text-decoration: underline;\">Healthcare does not feel the impact of the crisis<\/span><\/span><\/a><\/p>\n<p><strong><span style=\"color: #3366ff;\">If you want to know more or if you think we can help you, do not hesitate to contact us.<\/span><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Caixa Capital Risc, the \"la Caixa\" group's venture capital manager for early-stage innovative companies, which had 4 investment vehicles specialising in Biotechnology, Industry and ICT, has launched a new Biotech fund together with the CDTI.<\/p>","protected":false},"author":4,"featured_media":46053,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2277],"tags":[171,200],"sectores":[],"tipo-contenido":[2260],"class_list":["post-42308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiplos-de-empresas-cotizadas","tag-capital-riesgo","tag-inversores","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/42308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=42308"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/42308\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media\/46053"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=42308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=42308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=42308"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=42308"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=42308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}